DSE:BXPHARMA Market Cap

DSE:BXPHARMA has a market cap or net worth of 50.86 billion as of April 29, 2026. Its market cap has increased by 40.57% in one year.

Market Cap

50.86B

Enterprise Value

58.15B

Revenue

46.34B

Ranking

n/a

PE Ratio

8.00

Stock Price

114.00

Market Cap Chart

Since January 3, 2000, DSE:BXPHARMA's market cap has increased from 1.91B to 50.86B, an increase of 2,561.39%. That is a compound annual growth rate of 13.27%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	50.86B	11.66%
Dec 30, 2025	45.55B	25.12%
Dec 30, 2024	36.40B	-44.19%
Dec 28, 2023	65.22B	-
Dec 29, 2022	65.22B	-24.13%
Dec 30, 2021	85.97B	1.15%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 27, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Renata	47.77B
Unilever Consumer Care	40.16B
Beacon Pharmaceuticals	24.02B
The ACME Laboratories	15.93B
Square Pharmaceuticals PLC.	188.90B
Asiatic Laboratories	13.59B
The IBN SINA Pharmaceutical Industry	9.73B
Orion Pharma	6.27B

Market Cap Rankings